Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
General18 hours agoMan who shot poodle in Central Coast caravan park robbery sentenced to eight years in prison
-
Business21 hours agoMacquarie tips 40%+ upside for this ASX mining stock
-
Noosa News20 hours agoTanika Kristan Bromley and James Thomas Muir Wood, roommates of Pheobe Bishop, face court as Bundaberg murder case adjourned amid huge evidence backlog
-
General7 hours agoClean-up underway after stormy weather hits, 400 calls for help in Sydney